The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Patient with Irritable Bowel Syndrome Improved After Treatment with Sosiho-tang, Jakyakgamcho-tang, and Acupuncture: A Case Report

과민대장증후군 환자를 소시호탕 합 작약감초탕 및 침 치료로 호전시킨 1례 : 증례보고

  • Choi, Chiho (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kwon, Seungwon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
  • 최치호 (경희대학교 대학원 임상한의학과) ;
  • 권승원 (경희대학교 대학원 임상한의학과)
  • Received : 2022.09.16
  • Accepted : 2022.10.31
  • Published : 2022.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Irritable bowel syndrome is a functional disorder of the gastrointestinal tract marked by chronic abdominal pain and altered bowel habits. Irritable bowel syndrome is experienced by 11% of the global population. Although antidepressants and antispasmodic agents are currently used as therapeutic methods, they have side effects, so safer treatment agents are needed. Hence, I report the case of an outpatient who suffers from irritable bowel syndrome. Methods: The patient visited a public health center 14 times over four weeks and was treated with acupuncture and herbal medicine (Sosiho-tang and Jakyakgamcho-tang). Treatment progress was assessed using the Irritable Bowel Syndrome Severity Scoring System. Results: After 28 days of treatment, the Irritable Bowel Syndrome Severity Scoring System score decreased from 410 to 30 points without adverse events. The patient was highly satisfied. Conclusion: Sosiho-tang and Jakyakgamcho-tang with acupuncture might become recommended therapeutic options for irritable bowel syndrome patients.

Keywords

References

  1. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991 Oct;101(4):927-34. https://doi.org/10.1016/0016-5085(91)90717-Y
  2. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003 Mar 1;17(5):643-50. https://doi.org/10.1046/j.1365-2036.2003.01456.x
  3. Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016 Mar 24;2:16014.
  4. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel Disorders. Gastroenterology 2016:150(6):1393-1407.e5. https://doi.org/10.1053/j.gastro.2016.02.031
  5. Yang J, Deng Y, Chu H, Cong Y, Zhao J, Pohl D, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013 Mar;11(3):262-8. https://doi.org/10.1016/j.cgh.2012.11.034
  6. Johannesson E, Simren M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011 May; 106(5):915-22. https://doi.org/10.1038/ajg.2010.480
  7. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009 Jan;104(Suppl 1):S1-35.
  8. The Society of Internal Korean Medicine. Irritable Bowel Syndrome Clinical Practice Guideline of Korean Medicine. National Institute for Korean Medicine Development Korean Medicine Innovation Technology Development Project Team; 2022, p. 41.
  9. Hong EK, Lee JI, Park YC, Kwon DI, Sun DC, Kim JY, et al. A Case Report of Irritable Bowel Syndrome Treated with Daechilgitang-gagambang. J Orient Obstetr Gynecol 2007;20(1):268-76.
  10. Kim KT. Two Case Reports of Patients with Diarrhea-predominant Irritable Bowel Syndrome Treated with Jeoreongchajeonja-tang. J Int Korean Med 2019;40(5):948-56. https://doi.org/10.22246/jikm.2019.40.5.948
  11. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob Adv Health Med 2013;2(5) :38-43.
  12. Nagata K, Kamano Y, Kamano S, A clinical therapy for abdominal pains by Shakuyakukanzo-to. Pain and Kampo 1992;2:30.
  13. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997 Apr;11(2) :395-402. https://doi.org/10.1046/j.1365-2036.1997.142318000.x
  14. Spiegel B, Bolus R, Harris LA, Lucak S, Naliboff B, Esrailian E, et al. Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment Pharmacol Ther 2009;30(11-12):1159-70. https://doi.org/10.1111/j.1365-2036.2009.04144.x
  15. Hughes S, Sibelli A, Everitt HA, Moss-Morris R, Chalder T, Harvey JM, et al. Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study. J Med Internet Res 2020 Nov 20;22(11):e18691. https://doi.org/10.2196/18691
  16. Wang Y, Huang YQ, Zhu SL, Zhang CR, Chen XL, Hou QK, et al. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial. Trials 2020 Nov 3;21(1):908. https://doi.org/10.1186/s13063-020-04833-x
  17. Casado-Bedmar M, Keita AV. Potential neuro -immune therapeutic targets in irritable bowel syndrome. Therap Adv Gastroenterol 2020;13: 1756284820910630.
  18. Huang ST, Chen GY, Lo HM, Lin JG, LeeYS, Kuo CD. Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects. The American journal of Chinese medicine 2006;34(01):23-36. https://doi.org/10.1142/S0192415X06003606
  19. Lu MJ, Yu Z, He Y, Yin Y, Xu B. Electroacupuncture at ST36 modulates gastric motility via vagovagal and sympathetic reflexes in rats. World J Gastroenterol 2019 May 21;25(19):2315-26. https://doi.org/10.3748/wjg.v25.i19.2315
  20. Suganami A, Sakamoto K, Ono T, Watanabe H, Hijioka N, Murakawa M, et al. The inhibitory effect of shakuyakukanzoto on K+ current in H9c2 cells. Fukushima J Med Sci 2014;60(1): 22-30. https://doi.org/10.5387/fms.2013-16